| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 11/05/2008 | CN101298440A Pharmaceutical salts of reboxetine |
| 11/05/2008 | CN100430404C Spiro oxazone derivative containing naphthalimide unit |
| 11/05/2008 | CN100430384C Method for the production of 4-(4-aminophenyl)-3-morpholinon |
| 11/04/2008 | US7446210 Factor Xa compounds |
| 10/30/2008 | WO2008131259A1 Deuterated morpholinyl compounds |
| 10/30/2008 | WO2008130616A2 Diaryl morpholines as cb1 modulators |
| 10/30/2008 | WO2008129004A2 Heterocyclic compounds containing the morpholine nucleus their preparation and use |
| 10/30/2008 | US20080269483 Production of bepromoline |
| 10/30/2008 | US20080269221 Antibacterial agents |
| 10/30/2008 | US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease |
| 10/30/2008 | US20080269204 Benzolactam boronic acid compounds; blocking inflammatory cytokines and tumor necrosis ; phosphodiesterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders |
| 10/30/2008 | US20080269134 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| 10/30/2008 | US20080266647 High extinction coefficient switchable dyes allow thinner colorant filmsthat, in turn, require desirably lower pixel switching voltage for a given electric field in displays; ring-based tautomers, of which there may be more than one per chromophore, and may include donor and/or acceptor moieties. |
| 10/30/2008 | CA2684679A1 Heterocyclic compounds containing the morpholine nucleus their preparation and use |
| 10/29/2008 | EP1985297A1 Carboxylic acid compound and use thereof |
| 10/29/2008 | EP1984345A1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 10/29/2008 | EP1727809B8 Substituted morpholine and thiomorpholine derivatives |
| 10/29/2008 | EP1492776B1 Iodinated triglyceride analogs |
| 10/29/2008 | CN101296937A Asymmetric synthesis of peptides |
| 10/29/2008 | CN101296912A Theramutein modulators |
| 10/29/2008 | CN100429206C Benzoxazine derivatives as 5-HT6 modulators and uses thereof |
| 10/29/2008 | CN100429205C Preparation method of N-isotridecyl-2,6-dimethyl morpholine |
| 10/29/2008 | CN100429197C Compound of di-butanedione, complexes of europium, combination of containing the complexes and application |
| 10/28/2008 | US7442702 Prostaglandin agonists |
| 10/28/2008 | US7442696 5-Chloro-6-(3-cyanophenyl)-1,4-dihydro-4,4-dimethyl-2H-3,1-benzoxazin-2-one; congestive heart failure, hypertension, fibrosis, hyperaldosteronism, hypokalemia, liver cirrhosis, metabolic acidosis, hypoadrenocorticoidism, and Addison's disease; 3,1-benzoxazin-2-one derivatives |
| 10/28/2008 | US7442447 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes |
| 10/23/2008 | WO2008125342A2 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
| 10/23/2008 | WO2007075852A3 Calcium channel antagonists |
| 10/23/2008 | WO2007046022A3 Inhibitors of phosphodiesterase type-iv |
| 10/23/2008 | US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 10/23/2008 | US20080261985 treating a disorder characterized by the overexpression of iNOS or COX-2 genes; rheumatoid arthritis, inflammatory bowel disease, lupus, multiple sclerosis, or psoriasis; cancer |
| 10/23/2008 | US20080261983 5HT4 serotonin receptor agonist; chronic gastritis; heartburn; nausea and vomiting; and gastroesophageal reflux disease; coadministration with proton pump inhibitor; an H2 antagonist; an anti-flatulent; and pancreatin; 4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl-d2)benzamide |
| 10/23/2008 | US20080261978 treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers; 1-(4-((pyridin-2-ylmethylamino)methyl)benzyl)-3-phenylurea |
| 10/23/2008 | US20080261964 Substituted quinolones II |
| 10/23/2008 | US20080261963 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer |
| 10/23/2008 | DE112006002147T5 Polymerverbindung und polymere lichtemittierende Vorrichtung diese verwendend Polymer compound and polymer light emitting device using this |
| 10/23/2008 | DE102007018149A1 Substituted compound for producing pharmaceuticals for treating or prophylaxis of pain, nerve injuries, respiratory disorder, has general formulae |
| 10/23/2008 | CA2683461A1 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
| 10/22/2008 | EP1981861A2 Novel method for synthesis of 1,4-morpholine-2,5-diones |
| 10/22/2008 | EP1981859A2 Preparation of delmopinol |
| 10/22/2008 | EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
| 10/22/2008 | EP1417196B1 Dna-pk inhibitors |
| 10/22/2008 | CN101289403A Cyclopentaphenanthrene-based compound and organoelectroluminescent device employing the same |
| 10/22/2008 | CN100427528C Process for preparing modified benzoxazine |
| 10/22/2008 | CN100427475C Naproxen-2-aryl morpholine ethyl ester and its preparation method and uses |
| 10/21/2008 | US7439396 Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors |
| 10/21/2008 | US7439368 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 10/21/2008 | US7439356 Substituted indan derivatives |
| 10/16/2008 | WO2008123017A1 Novel diamide derivative |
| 10/16/2008 | WO2008077647A3 Alpha- amino alcohols as non-steroidal progesterone receptor modulators |
| 10/16/2008 | US20080255351 Method for Preparing Aminodiglycol (Adg) and Morpholine |
| 10/16/2008 | US20080255124 4-[(Cyclopropylmethyl)(2-{[4-(1,1-dimethylethyl)phenyl]oxy}ethyl)amino]-2-(trifluoromethyl)benzonitrile; modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors; osteoporosis, muscle wasting,endometriosis, cardiovascular disease; breast, uterine cancer, prostatic hyperplasia |
| 10/16/2008 | US20080255109 Antigonadotrophins; breast and prostate cancer, endometriosis, benign prostate hyperplasia; regulation of fertility; 4-(3-Chloro-4-{{(4-chloro-benzenesulfonyl)-methyl-amino]-methyl}-thiophene-2-carbonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-2carboxylic acid (3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-amide |
| 10/16/2008 | US20080255108 Novel thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 10/16/2008 | US20080255105 Biphenyl Derivatives and Their Use in Treating Hepatitis C |
| 10/16/2008 | US20080255102 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence |
| 10/16/2008 | US20080251169 Ionic liquid, a method of synthesizing an ionic liquid, a precursor of an explosive composition including at least one ionic liquid, and a method of desensitizing an explosive composition |
| 10/15/2008 | EP0923544B1 Method for the synthesis of amines and amino acids with organoboron derivatives |
| 10/14/2008 | US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer |
| 10/09/2008 | WO2008120093A1 Sulfonamides and pharmaceutical compositions thereof |
| 10/09/2008 | WO2008119685A2 Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators |
| 10/09/2008 | WO2008090193A3 Method for producing betamimetics |
| 10/09/2008 | US20080249087 Heterocylic antiviral compounds |
| 10/09/2008 | US20080248093 pH sensitive prodrugs of 2,6-diisopropylphenol |
| 10/08/2008 | CN101283019A Polymer and light-emitting polymer element using the same |
| 10/08/2008 | CN100424135C Colorants produced by reaction of oxyalkylene-substituted aminophenol intermediate |
| 10/07/2008 | US7432372 Fluorinated resorufin compounds and their application |
| 10/07/2008 | US7432258 4'-[(1R)-1-[[(6,7-dichloro-3-oxo-2,3-dihydro-4H-1,4-benzoxazin- 4-yl)acetyl](methyl)amino]-2-(4-morpholinyl)ethyl]-4-biphenylcarboxylic acid; as antagonists of urotensin II, congestive heart failure, stroke, ischemic heart disease (e.g. angina, myocardial ischemia), cardiac arrhythmia, hypertension |
| 10/07/2008 | US7432257 Piperdinyl-phenoxazine and phenothiazine derivatives as δ-opioid modulators |
| 10/02/2008 | US20080242698 Antiepilrptic agents; antiischemic agents; vision defects; skin disorders; muscular disorders; anticonvulsants;analgesics; Parkinson's disease; huntington's disease; amyotrophic lateral sclerosis; multiple sclerosis |
| 10/02/2008 | US20080242671 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide |
| 10/02/2008 | US20080242662 substituted 3,4- or higher substituted piperazine compounds; renin inhibitor; antidiabetic, analgesic,hypotensive agent; neurodegenerative diseases; preparation by reacting a carbonic acid with amino compound |
| 10/02/2008 | US20080241948 Mycophenolate mofetil impurity |
| 10/02/2008 | DE102007015034A1 Lactam-substituierte Dicarbonsäuren und ihre Verwendung Lactam substituted dicarboxylic acids and their use |
| 10/01/2008 | EP1973875A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 10/01/2008 | CN101277939A Acyclic ikur inhibitors |
| 10/01/2008 | CN100422177C Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine |
| 10/01/2008 | CN100422161C Hydroxymorpholinone derivative and medicinal use thereof |
| 10/01/2008 | CN100422160C Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 10/01/2008 | CN100421665C Mitotic kinesin inhibitors |
| 09/30/2008 | US7429603 C-fms kinase inhibitors |
| 09/30/2008 | US7429589 4-Morpholino-2-nitroanisole; antidepressant; reacting Morpholinoanisole, Nitric Acid Salt with sulfuric acid and after dilution with water treating the solution with base to reach a pH of greater than 10; exothermic reaction; safer nitration processes and better control of chemistry |
| 09/25/2008 | WO2008115804A1 Novel ido inhibitors and methods of use thereof |
| 09/25/2008 | WO2007120511A3 Methods for synthesizing ammonia borane |
| 09/25/2008 | US20080234274 Novel Compounds |
| 09/25/2008 | US20080234257 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
| 09/25/2008 | US20080234247 Heterocyclic analgesic compounds and methods of use thereof |
| 09/24/2008 | CN101273022A Thiazoles derivatives as AMPK activator |
| 09/24/2008 | CN101270098A Method for preparing high-purity cis-2,6-dimethyl morpholine |
| 09/23/2008 | US7427683 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer |
| 09/23/2008 | US7427618 e.g. 2-[3-(4-ethynylphenyl)ureido]-N-[4-(3-oxomorpholin-4-yl)phenyl]valeramide; anticoagulant, antitumor factor; thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, claudicatio intermittens, or migraine |
| 09/23/2008 | US7427614 treatment of glaucoma or ocular hypertension; N-substituted hexahydropyrimidin-2-ones, perhydro-1,3-oxazin-2-ones and perhydro-1,3-thiazin-2-ones |
| 09/18/2008 | WO2008111669A1 Novel prophylactic and/or therapeutic agent for diabetic neuropathy |
| 09/18/2008 | WO2008111668A1 Novel prophylactic and/or therapeutic agent for neurogenic pain |
| 09/18/2008 | WO2008111300A1 Novel diamide derivative |
| 09/18/2008 | WO2008110466A1 Nitroxides for lithium-ion batteries |
| 09/18/2008 | US20080227961 Chelation compounds, radionuclides |
| 09/18/2008 | US20080227959 Immunogenic compounds for producing antibodies to efavirenz; monoclonal antibodies; immunoassays for selectively determining efavirenz levels in plasma; treatment failure and central nervous system side effects due to low and high plasma levels, respectively |
| 09/18/2008 | CA2680938A1 Novel preventive and/or therapeutic agent for diabetic neuropathy |
| 09/18/2008 | CA2680935A1 Novel preventive and/or therapeutic agent for neuropathic pain |